Comparison and effects of acute lamotrigine treatment on extracellular excitatory amino acids in the hippocampus of PTZ-kindled epileptic and PTZ-induced status epilepticus rats

Neurochemical Research

Volumn 38, Issue 3, 2013, Pages 504-511

  Deng, Yan ^a,b   Wang, Minghuan ^b   Wang, Wei ^a   Ma, Chao ^b   He, Nongyue ^a,b  

^a HUNAN UNIVERSITY OF TECHNOLOGY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Comparison; Effect; Epilepsy; Excitatory amino acid (EAA); Lamotrigine (LTG); Pentylenetetrazol (PTZ)

Indexed keywords

ASPARTIC ACID; EXCITATORY AMINO ACID; GLUTAMIC ACID; LAMOTRIGINE; PENTETRAZOLE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; EPILEPTIC STATE; HIPPOCAMPUS; KINDLING; MALE; MICRODIALYSIS; NERVE CELL EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; ASPARTIC ACID; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MALE; NEUROTRANSMITTER AGENTS; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; TRIAZINES;

RATTUS;

EID: 84876417747     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0942-7     Document Type: Article

References (45)

1. Bazil CW (2002) New antiepileptic drugs. Neurol 8:71-81
2. Kwan P, Sills GJ, Brodie MJ (2001) The mechanism of action of commonly used antiepileptic drugs. Pharmacol Ther 90:21-34
3. Ferrie CD, Panayiotopoulos CP (1994) Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Seizure 3:157-159
4. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP (1995) Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 91:200-202
5. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A (1999) The efficacy of valproate lamotrigine comedication in refactory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40:1141-1146
6. Hwang H, Kim H, Kim SH, Kim SH, Lim BC, Chae JH, Choi JE, Kim KJ, Hwang YS (2012) Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. Brain Dev 34:344-348
7. Arban R, Maraia G, Brackenborough K, Winyard L, Wilson A, Gerrard P, Large C (2005) Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 158:123-132
8. Coderre TJ, Kumar N, Lefebvre CD, Yu JSC (2007) A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 100:1289-1299
9. Lee HJ, Ertley RN, Rapoport SI, Bazinet RP, Rao JS (2008) Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex. Neurochem Res 33:861-866
10. Chang YYC, Rapoport SI, Rao JS (2009) Chronic administration of mood stabilizers upregulates BDNF and Bcl-2 expression levels in rat frontal cortex. Neurochem Res 34:536-541
11. Cunningham MO, Jones RSG (2000) The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vivo. Neuropharmacol 39:2139-2141
12. Cunninham MO, Dhillon A, Wood SJ, Jones RS (2000) Reciprocal modulation of glutamate and GABA release may underlie the anticonvulsant effect of phenytoin. Neurosci 95:343-351
13. Shuaib A, Mahmood RH, Wishart T, Kanthan R, Murabit MA, Ijas S, Miyashita H, Howlett W (1995) Neuroprotective effects of lamotrigine in global ischaemia in gerbils. A histological in vivo microdialysis and behavioural study. Brain Res 702:199-206
14. Bacher A, Zornow MH (1997) Lamotrigine inhibits extracellular glutamate accumulation during transient global ischaemia in rabbits. Anaesthesiol 86:459-463
15. Ahmad S, Fowler LJ, Whitton PS (2004) Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats. Brain Res 1029:41-47
16. Paraskevas GP, Triantafyllou NI, Kapaki E, Limpitaki G, Petropoulou O, Vassilopoulos D (2006) Add-on lamotrigine treatment and plasma glutamate levels in epilepsy: relation to treatment response. Epilepsy Res 70:184-189
17. Eriksson A-S, O'Connor WT (1999) Analysis of CSF amino acids in young patients with generalized refractory epilepsy during an add-on study with lamotrigine. Epilepsy Res 34:75-83
18. Tomczyk T, Haberek G, Zuchora B, Jaroslawska-Zych A, Kowalczyk MS, Wielosz M, Urbanska EM (2007) Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures. Pharmacological Repor 59:462-466
19. Lee C-Y, Fu W-M, Chen C-C, Su M-J, Liou H-H (2008) Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 49(5):888-897
20. Doi T, Ueda Y, Nagatomo K, Willmore LJ (2009) Role of glutamate and GABA transportersin development of pentylenetetrazol-kindling. Neurochem Res 34:1324-1331
21. Hussenet F, Boyet S, Nehlig A (1995) Long-term metabolic effects of pentylenetetrazol -induced status epilepticus in the immature rat. Neuroscience 67(2):455-461
22. Li Z-P, Zhang X-Y, Lu X, Zhong M-K, Ji Y-H (2004) Dynamic release of amino acid transmitters induced by valproate in PTZ-kindled epileptic rat hippocampus. Neurochem Int 44:263-270
23. Sherwin A, Robitaille Y, Quesney F, Olivier A, Leblanc R, Feindel W, Andermann E, Gotman J, Andermann F (1988) Exicitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 38:920-923
24. Janhua NA, Itano T, Kugoh T, Hosokawa K, Nakano M, Matsui H, Hatase O (1992) Familial increase in plasma glutamic aid in epilepsy. Epilepsy Res 11:37-44
25. Wilson CL, Maidment NT, Ohomer MH, Behnke EJ, Ackerson L, Fried I, Engel J Jr (1996) Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainite rat model of hippocampal epilepsy. Epilepsy Res 265:245-254
26. Schroder H, Becker A (1996) The role of glutamate receptors in pentylenetetrazole kindling of rats-a neurochemical study. Neuropharmacology 35:A28
27. Schroder H, Becker A, Loβner B (1993) Glutamate binding to brain membrane is increased in pentylenetetrazole-kindled rats. J Neurochem 60:1007-1011
28. 3H-D-aspartate release from hippocampal tissue during the development of pentylenetetrazol kindling in rats. Pharmacol Biochem Behav 62:349-352
29. Ekonomou A, Angelatou F (1999) Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced "kindling" model of epilepsy. Neurochem Res 24:1515-1522
30. Hamberger A, Nystrom B, Larsson S, Silfvenius H, Nordborg C (1991) Amino acids in the neuronal microenvironment of focal human epileptic lesions. Epilepsy Res 9:32-43
31. Carlson H, Ronne-Engstrom E, Ungerstedt U, Hillered L (1992) Seizure related elevations of extracellular amino acids in human focal epilepsy. Neurosci Lett 140:30-32
32. During MJ, Spencer DD (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607-1610A
33. Giorgi O, Orlandi M, Lecca D, Corda MG (1991) MK-801 prevents chemical kindling induced by pentylenetetrazol in rats. Eur J Pharmacol 193:363-635
34. Sayin U, Cengiz S, Altug T (1993) Vigabatrin as an anticonvulsant against pentylenetetrazole seizures. Pharmacol Res 28:325-331
35. da Silva LF, Pereira P, Elisabetsky E (1998) A neuropharmacological analysis of PTZ-induced kindling in mice. Gen Pharmac 31:47-50
36. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1-105
37. Chapman AG (2000) Glutamate and epilepsy. J Nutr 130:1043S-1045S
38. Chao X-D, Fei F, Fei Z (2010) The role of excitatory amino acid transporters in cerebral ischemia. Neurochem Res 35:1224-1230
39. White HS, Wolf HH, Woodhead JH, Kupferberg HJ (1998) The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. In: French J, Leppik I, Dichter MA (Eds.), Antiepileptic Drug Development. Advancesin Neurology vol. 76. Lip-pincott-Raven, Philadelphia, pp. 29-39
40. Lees G, Leach MJ (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamactil) using primary neurological cultures from rat cortex. Brain Res 612:190-199
41. Wang SJ, Sibra TS, Gean PW (2001) Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuro Report 12:2255-2258
42. + channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons. Neurochem Res 35:2175-2183
43. Waldmeier PC, Baumann PA, Wick P, Feldtrauer JJ, Stierlin C, Scmutz M (1995) Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907-1913
44. 3H]aspartate from mouse cerebral cortical slices. Neurochem Res 24:1153-1159
45. Zachar G, Wagner Z, Tabi T, Balint E, Szoko E, Csillag A (2012) Differential changes of extracellular aspartate and glutamate in the striatum of domestic chicken evoked by high potassium or distress: an in vivo microdialysis study. Neurochem Res 37:1730-1737